AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Assess tax efficiency between S&P 500 ETFs and index funds for retirement, focusing on taxes, distributions, and long-term strategy.
28,172 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Bitcoin hovers near a pivotal zone as bulls and bears clash. Analysts warn of a potential break below key supports, s...
Meta is pursuing a new play-money prediction market, Arena, designed to test engagement and data signals while naviga...
XRP rebounded 8% this week, but the market remains range-bound. Traders eye key support and a critical breakout zone ...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
SK Hynix shares rebound 8% amid bargain-hunting after HSBC reaffirmed SKHY as a top chip pick. The move comes as inve...
Synopsys is set to report its fiscal Q1 results after the bell today. Traders will watch for IP-unit performance and ...
XRP is mired in a short-term pullback as buyers hesitate near $1.40. With two red weekly candles, analysts flag a pot...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
A March 17, 2026 report from Muddy Waters Research targets SoFi Technologies, spurring volatility as KBW weighs in. S...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
A ransomware attack on Canvas disrupted finals across thousands of schools as the ShinyHunters group claimed responsi...